Kathryn Flanagan

Kathryn Flanagan is an experienced professional in clinical trial operations, currently serving as an eTMF Manager at KalVista Pharmaceuticals, Inc. since November 2021 and previously as a Clinical Trial Associate at The Medicines Company from June 2018. In these roles, Kathryn has demonstrated strong capabilities in maintaining study documents for cardiovascular studies, managing electronic and paper trial master files (TMF), and ensuring regulatory compliance through cross-functional collaboration. Prior experience includes a Sr. Clinical Trial Assistant position at DOCS and internships at The Medicines Company and The Alcohol and Drug Abuse Prevention Team, where Kathryn focused on enhancing clinical operations and engaging in community education. Kathryn holds a Bachelor of Science degree in Public Health from Montclair State University.